Skip to Content

PPG specializes in intellectual property law in the biotech, pharmaceutical, and chemical industries. Our lawyers leverage their deep scientific, legal, and business expertise to create effective IP strategies that others can’t envision.

PPG’s team is uniquely positioned to help pioneers in the life sciences and chemical fields turn breakthrough discoveries into products that succeed at market.

We know the science behind our clients’ pacesetting research, and we excel at generating creative strategies that safeguard their breakthroughs and maximize market potential.

Insights

Biotech Patent Protection: How to Successfully Protect Your Invention

Biotech innovations drive progress, holding the promise of transforming lives. Safeguarding these groundbreaking discoveries and inventions through intellectual property (IP) rights, particularly patents, is crucial.
 
Encompassing fields such as pharmaceuticals, gene and cell therapy, and immunotherapy, biotech represents a scientific frontier with the potential to address global challenges from healthcare to agriculture. However, transitioning a scientific discovery to a patentable invention requires careful legal evaluation and strategic planning.

How we are different

Not just smart - strategic.

We understand the complex concepts underlying scientific discoveries and the business strategies behind their development. This dual knowledge helps us find solutions that others can’t envision.

How we are different

Creative where it counts.

We develop novel approaches to capture the fullest, most advantageous scope for each patent. Our solutions are innovative and practical, always with an eye toward our clients’ business goals.

How we are different

Relationships are the foundation of all we do.

We develop and nurture long-term partnerships built on mutual trust, personalized attention, willingness to invest time in our clients’ businesses, and the alignment of goals and values.

Pabst Patent Group combines the intellectual property law expertise of a large law firm and the personalization of a smaller firm to give their clients the best of both worlds.
  • DR. TERRENCE W. NORCHI
    President, Chief Executive Officer and Director
    Arch Therapeutics, Inc.